Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-14

Clinical Trial Update: Omega 3 and Ischemic Stroke; Fish Oil as an Option [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigates the use of omega-3/fish oil for ischemic stroke and neurological injury, with status currentlyUNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (fish oil) (omega-3 fatty acids)

Snippet

Sponsor: King Fahad Medical City | Conditions: Ischemic Stroke, Neurological Injury | Phase 4 | Status: UNKNOWN